LRRK2 and ubiquitination: Implications for Kinase inhibitor therapy

Medicine & Life Sciences

• Ubiquitination 85%
• Leucine 81%
• Phosphotransferases 61%
• Therapeutics 12%
• Rodentia 7%
• ras Proteins 5%
• GTP Phosphohydrolases 5%
• Protein Domains 4%
• Protein Binding 4%
• Primates 4%
• Protein Kinases 4%
• Phosphorylation 3%
• Phenotype 2%
• Mutation 2%
• Brain 2%
• Pharmaceutical Preparations 1%
• Proteins 1%

Chemical Compounds

• Phosphotransferase Inhibitor 100%
• Dephosphorylation 49%
• Mutation 33%
• Protein 32%
• Pharmaceutical 28%